Citations for
1NOL7, THBS1
The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.
Doçi CL, Zhou G, Lingen MW.
Oncogene 32(37):4377-86. doi: 10.1038/onc.2012.464. Epub 2012 Oct 22. 2013
2NOL7, RB1
The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7.
Mankame TP, Lingen MW.
Neoplasia 14(12):1213-22. 2012
3NOL7
Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.
Doçi CL, Mankame TP, Langerman A, Ostler KR, Kanteti R, Best T, Onel K, Godley LA, Salgia R, Lingen MW.
Int J Gynecol Pathol 31(1):15-24. doi: 10.1097/PGP.0b013e318220ba16. 2012
4NOL7
The dynamics of the alternatively spliced NOL7 gene products and role in nucleolar architecture.
Kinor N, Shav-Tal Y.
Nucleus 2(3):229-45. doi: 10.4161/nucl.2.3.15893. 2011
5NOL7
Identification and characterization of the human NOL7 gene promoter.
Mankame TP, Zhou G, Lingen MW.
Gene 456(1-2):36-44. Epub 2010 Mar 3.PMID: 20206243 2010
6NOL7
Identification and functional analysis of NOL7 nuclear and nucleolar localization signals.
Zhou G, Doçi CL, Lingen MW.
BMC Cell Biol 11:74. doi: 10.1186/1471-2121-11-74. 2010
7NOL7
NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype.
Hasina R, Pontier AL, Fekete MJ, Martin LE, Qi XM, Brigaudeau C, Pramanik R, Cline EI, Coignet LJ, Lingen MW.
Oncogene 25(4):588-98. 2006
8BUD23, MED21, NOL7, SMC2, UTP4
Nucleolar proteome dynamics.
Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M.
Nature 433(7021):77-83. 2005